Possible Value of Antifibrotic Drugs in Patients with Progressive Fibrosing Non-IPF Interstitial Lung Diseases

被引：0
|
作者：
Torrisi, S. [1 ,2 ,3 ]
Kahn, N. C. [1 ,2 ,3 ]
Waelscher, J. [1 ,2 ,3 ]
Sarmand, N. [1 ,2 ,3 ]
Polke, M. [1 ,2 ,3 ]
Heussel, C. [2 ,3 ,4 ]
Palmucci, S. [5 ]
Sambataro, G. [6 ]
Vancheri, C. [6 ]
Kreuter, M. [1 ,2 ,3 ]
机构：
[1] Heidelberg Univ, Ctr Interstitial & Rare Lung Dis, Thoraxklin, Heidelberg, Germany
[2] Translat Lung Res Ctr Heidelberg, Heidelberg, Germany
[3] German Ctr Lung Res, Heidelberg, Germany
[4] Heidelberg Univ, Thoraxklin, Radiol, Heidelberg, Germany
[5] Univ Hosp, Dept Med Surg Sci & Adv Technol, Radiol Unit 1, Catania, Italy
[6] Univ Catania, Dept Clin & Expt Med, Reg Referral Ctr Rare Lung Dis, AOU Policlin Vittorio Emanuele, Catania, Italy
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4765
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    Finnerty, James Patrick
    Ponnuswamy, Aravind
    Dutta, Prosjenjit
    Abdelaziz, Ammar
    Kamil, Hafiz
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [42] Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
    Vincent Cottin
    Luca Richeldi
    Ivan Rosas
    Maria Otaola
    Jin Woo Song
    Sara Tomassetti
    Marlies Wijsenbeek
    Manuela Schmitz
    Carl Coeck
    Susanne Stowasser
    Rozsa Schlenker-Herceg
    Martin Kolb
    Respiratory Research, 22
  • [43] Comment on "The natural history of progressive fibrosing interstitial lung diseases"
    Moodley, Yuben P.
    Zappala, Christopher
    Tedja, Chantalia
    Clynick, Britt
    Tan, Dino B. A.
    Walters, Eugene Haydn
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (06)
  • [44] Role of imaging in progressive-fibrosing interstitial lung diseases
    Walsh, Simon L. F.
    Devaraj, Anand
    Enghelmayer, Juan Ignacio
    Kishi, Kazuma
    Silva, Rafael S.
    Patel, Nina
    Rossman, Milton D.
    Valenzuela, Claudia
    Vancheri, Carlo
    EUROPEAN RESPIRATORY REVIEW, 2018, 27 (150):
  • [45] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    James Patrick Finnerty
    Aravind Ponnuswamy
    Prosjenjit Dutta
    Ammar Abdelaziz
    Hafiz Kamil
    BMC Pulmonary Medicine, 21
  • [46] Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
    Wollin, Lutz
    Distler, Joerg H. W.
    Redente, Elizabeth F.
    Riches, David W. H.
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Maher, Toby M.
    Kolb, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (03)
  • [47] Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
    Cottin, Vincent
    Richeldi, Luca
    Rosas, Ivan
    Otaola, Maria
    Song, Jin Woo
    Tomassetti, Sara
    Wijsenbeek, Marlies
    Schmitz, Manuela
    Coeck, Carl
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Kolb, Martin
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [48] The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases: Subgroup with Autoimmune Diseases
    Matteson, Eric
    Kelly, Clive
    Distler, Joerg
    Mann-Vold, Anna Maria Hoff
    Seibold, James
    Mittoo, Shikha
    Distler, Oliver
    Goeldner, Rainer-Georg
    Schlenker-Herceg, Rozsa
    Stowasser, Susanne
    Quaresma, Manuel
    Flaherty, Kevin
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [49] Lung Function Decline and Hospitalization Among Patients with non-IPF Fibrosing Interstitial Lung Disease as Observed in a Large Real-World Electronic Health Record Database
    Singer, D.
    Chastek, B. J.
    Johnson, J. C.
    Shetty, S.
    Conoscenti, C. S.
    Bernstein, E. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [50] Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases
    Brown, Kevin K.
    Inoue, Yoshikazu
    Flaherty, Kevin R.
    Martinez, Fernando J.
    Cottin, Vincent
    Bonella, Francesco
    Cerri, Stefania
    Danoff, Sonye K.
    Jouneau, Stephane
    Goeldner, Rainer-Georg
    Schmidt, Martin
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Wells, Athol U.
    RESPIROLOGY, 2022, 27 (04) : 294 - 300
12345